Skip to main content
. 2020 Nov 23;10:405. doi: 10.1038/s41398-020-01089-6

Fig. 3. Malleability of gamma-evoked power after 1 h of TCT predicts overall improvement in global positive symptom severity.

Fig. 3

Decomposing the significant ΔγEP × treatment interaction on change in SAPS Global (ΔR2 = 0.10, p = 0.002) revealed that the effect was largely driven by the TCT group (R2 = 0.49) and was absent in the TAU group (R2 < 0.01).